Jeena Sikho Lifecare Limited

Jeena Sikho Lifecare Limited to attend Analyst/Investor Meet

Jeena Sikho Lifecare Limited (JSLL) will be meeting with investors and analysts in Singapore on December 1st and 2nd, 2025 for physical group meetings.

JSLL Announces Publication of Research Articles and Case Studies

JSLL announces the publication of 39 research articles and case studies on Ayurvedic treatments for various diseases, authored by company-associated medical professionals, demonstrating their commitment to advancing Ayurvedic research.

Jeena Sikho Lifecare Reports Strong Q2 FY26 Results; Concall Transcript Released with Growth Outlook

JSLL's Q2 FY26 concall transcript showed strong revenue and profit growth. Key updates: increased bed capacity, Chandan Diagnostic partnership, and 10 new OTC product launches by FY26 end.

Jeena Sikho Lifecare's Ayurveda Panchkarma Hospital Empanelled with Maruti Suzuki India Limited

Jeena Sikho Lifecare's Ayurveda Panchkarma Hospital has been empanelled with Maruti Suzuki India Limited to provide cashless treatments to its employees and beneficiaries, enhancing its service reach.

Jeena Sikho Lifecare Publishes Q2 FY26 Unaudited Financial Results in Newspapers

JSLL published newspaper clippings of its unaudited standalone and consolidated financial results for the quarter ended September 30, 2025, following board approval on November 6, 2025.

JSLL Announces Audio Recording of Earnings Conference Call

Jeena Sikho Lifecare Limited (JSLL) has released the audio recording of its earnings conference call held on 7th November 2025 to discuss Q2 FY 2025-26 results.

Jeena Sikho Lifecare Reports Robust Q2 FY26 Performance with 66% YoY Revenue Growth

Jeena Sikho Lifecare announced strong Q2 FY26 results with 66% YoY revenue growth, 129% EBITDA increase, and improved margins. Operational expansion and new product launches further bolster positive outlook.

JSLL Board Approves Q2 FY26 Results and Appoints New Internal Auditors

Jeena Sikho Lifecare's board approved Q2 FY26 unaudited financial results and appointed Deepak K Garg & Associates as internal auditors for FY2025-26 in a meeting on November 6, 2025.

Jeena Sikho Lifecare Board Approves Q2 FY26 Results and Appoints New Internal Auditor

Jeena Sikho Lifecare's Board approved Q2 FY26 standalone and consolidated financial results for the quarter ended September 30, 2025, and appointed M/s. Deepak K Garg and Associates as the new Internal Auditor.

JSLL Approves Un-Audited Quarterly Results & Appoints Internal Auditor

Jeena Sikho Lifecare Limited approved the un-audited quarterly financial results and appointed M/s Deepak K Garg & Associates as the Internal Auditors at its board meeting held on November 6, 2025.

Jeena Sikho Lifecare Limited Announces Q2 FY26 Earnings Conference Call

Jeena Sikho Lifecare Limited will host an earnings conference call on November 7, 2025, at 01:30 PM IST to discuss the operational and financial performance for Q2 FY26.

JSLL Announces National Launch and Expansion of 'Pet Shuddhi' Product

Jeena Sikho Lifecare Limited launched its 'Pet Shuddhi' product line nationally on October 13, 2025. The 'Pet –Yakrit –Pleeha Shuddhi Kit' will be available across India through the Jeena Sikho Hospitals Network.

JSLL Announces Exclusive Diagnostic Collaboration with Chandan Healthcare

Jeena Sikho Lifecare Limited partners with Chandan Healthcare for exclusive diagnostic services across its facilities, enhancing healthcare offerings and patient experience.

JSLL Board approves exclusive diagnostic partnership with Chandan Healthcare and warrant subscription

Jeena Sikho Lifecare's board approved a 5-year exclusive diagnostic collaboration with Chandan Healthcare and subscribed to ₹42.12 crore convertible warrants in Chandan's preferential issue.

JSLL: Certificate under SEBI Regulations for Quarter Ended September 30, 2025

JSLL submitted a certificate under SEBI regulations for the quarter ended September 30, 2025, confirming compliance with depositories and participants' regulations.

JSLL: Proceedings of 8th AGM held on September 29, 2025

Jeena Sikho Lifecare commences operations of new 230-bed hospital in Raigad, Maharashtra

Acharya Manish Grover Conferred with Grand Records Honorary Certificate

Jeena Sikho Lifecare MD Honored with 6th National Atal Award for Indian Ayurveda

JSLL to attend DAM Capital’s Pharmaceutical Conference on 23 Sep 2025

Jeena Sikho Lifecare incorporates wholly-owned subsidiary in UAE for international expansion

Jeena Sikho Lifecare Limited Commences Operations of New 40-Bed Hospital in Jammu

JSLL collaborates with Salesforce for Digital Transformation in Ayurvedic Healthcare

JSLL commences operations of its new hospital in Jammu

JSLL Receives Approval for Clinical Trials of Anti-Diabetes & Other Products

JSLL Announces 8th AGM, E-Voting, and Dividend of ₹1.10 per share

JSLL Announces Publication of Case Studies and Reports

JSLL to Establish New Hospital in Bhagalpur, Bihar

Jeena Sikho Lifecare's Ayurveda Hospital Empanelled with GIPSA for Cashless Treatment

JSLL announces 8th Annual General Meeting on September 29, 2025

JSLL sets record date for final dividend of ₹1.10 per share

JSLL to attend Ashwamedh - Elara India Dialogue 2025 Conference

JSLL Publishes Case Studies Validating Ayurvedic Treatments for Liver Disorders, Infertility & Diabetes

Jeena Sikho Lifecare Board Approves ESOP, Appoints COO, and Declares ₹1.10 Dividend

JSLL unveils India’s first Pet-Yakrit-Pleeha Shuddhi Kit for triple detoxification

JSLL Empanelled under CBSE for Medical Facilities

JSLL achieves strong Q1 FY26 with 74% YoY revenue growth

JSLL's Agra & Panchkula facilities receive NABH certification until July 2028

Jeena Sikho Lifecare (JSLL) Q1 FY26 Earnings Call Recording Now Available

Jeena Sikho Lifecare Reports Robust Q1 FY26 Growth and Successful Mainboard Migration

JSLL to hold conference call for Q1 FY26 results on August 18, 2025